Our solutions

ProterixBio solutions: overview

Flexible and efficient clinical grade biomarker testing – for research or clinical applications

Our clinical laboratory has extensive experience adapting a variety of commercially available immuno / protein assay reagent-systems for clinical grade or fit-for-purpose performance in target populations. We are technology-agnostic, deploying the right tool for the project at hand, and our work to date spans a wide range of therapeutic areas – including infectious disease, respiratory disease, neurodegenerative disease and cardiovascular disease.

Our key customer segments include hospitals / medical centers, pharma / biotech, and companies providing or seeking to develop advanced diagnostic testing solutions. Selected examples of ongoing, executed or planned end-to-end research or clinical solutions include:

  • Development, validation and delivery of protein biomarker testing – on established and emerging technology platforms
  • Validation of end-to-end assay performance under CLIA
  • Implementation of time-sensitive clinical testing
  • Evaluation of devices and pre-analytical protocols to determine feasibility of a patient-centric clinical test
  • Screening of reagents for identified targets to determine applicable assay performance
  • Specificity testing, assay development and optimization in preparation for resting of human specimen collections
  • HIPAA-compliant software solution for ordering, accessioning and results reporting

If you are interested in a CLIA testing partner or need an end-to-end immuno / protein assay solution for research or clinical purposes, please contact us to learn more about our custom immunoassay services.

Learn about our assay development, validation and testing services

Learn about our technology platforms

Learn about our microsampling capabilities

Learn more about ProterixBio’s Services: